טוען...
Co-Delivery of Autoantigen and Dexamethasone in Incomplete Freund’s Adjuvant Ameliorates Experimental Autoimmune Encephalomyelitis
Current therapies for autoimmune diseases focus on treating the symptoms rather than the underlying disease cause. A major setback in improving current therapeutics for autoimmunity is the lack of antigen specificity. Successful antigen-specific immunotherapy (ASIT) would allow for improved treatmen...
שמור ב:
| הוצא לאור ב: | J Control Release |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5723532/ https://ncbi.nlm.nih.gov/pubmed/28963036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2017.09.034 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|